From potential to practice: how accelerating access to HPV tests and screen and treat programmes can help eliminate cervical cancer

Family Medicine and Community Health
William CherniakShannon Silkensen

Abstract

Human papillomavirus (HPV) vaccination campaigns to prevent cervical cancer are being considered and implemented in countries around the world. While vaccination will protect future generations, it will not help the millions of women currently infected, leading to an estimated 311 000 deaths per year globally. This paper examines a selection of strategies that when applied to both existing and new technologies, could accelerate access to HPV testing. Authors from the US Agency for International Development, the National Institutes of Health, and the Bridge to Health Medical and Dental, a non-governmental organisation, joined forces to propose a scalable and country-directed solution for preventing cervical cancer using an end-to-end approach. Collectively, the authors offer seven evidence-based strategies, that when used alone or in combination have the ability to reduce HPV-caused cervical cancer deaths and disability. These strategies include (1) consistent HPV test intervals to decrease HPV DNA test costs; (2) exploring market shaping opportunities; (3) employing iterative user research methodologies like human-centred design; (4) target product profiles for new HPV tests; (5) encouraging innovation around cervical cancer sc...Continue Reading

References

Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Jun 28, 2001·JAMA : the Journal of the American Medical Association·S J GoldieT C Wright
Dec 7, 2007·Obstetrics and Gynecology Clinics of North America·Mahboobeh SafaeianPhilip E Castle
Feb 2, 2011·Journal of the National Cancer Institute·Mark SchiffmanPhilip E Castle
May 9, 2012·Virchows Archiv : an International Journal of Pathology·Adhemar Longatto-FilhoKari Syrjänen
Aug 16, 2012·Bulletin of the World Health Organization·Agnes BinagwahoFidele Ngabo
Aug 31, 2012·Nature·James Mitchell Crow
Jan 29, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kayode Olusegun AjenifujaMark Schiffman
Jan 7, 2014·International Journal of Cancer. Journal International Du Cancer·Myassa Arkam DartellSusanne Kruger Kjaer
Feb 22, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jose JeronimoUNKNOWN START-UP Study Group
Mar 7, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·L DolmanR Sankaranarayanan
Jun 21, 2014·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Srabani MittalPartha Basu
Oct 25, 2016·Vaccine·Benjamin D GrantRebecca Richards-Kortum
Apr 4, 2017·International Journal of Cancer. Journal International Du Cancer·Catherine de MartelSilvia Franceschi
May 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emily A BurgerPhilip E Castle
Jul 12, 2017·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Heather L WhiteOlivia Nuccio
Aug 24, 2017·Journal of Global Oncology·Mauricio MazaMiriam L Cremer
Dec 6, 2017·IEEE Journal of Translational Engineering in Health and Medicine·Karen HaneyPaul C Pearlman
Jan 23, 2018·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Margaret WangFanghui Zhao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.